Implications of Angiogenesis Involvement in Arthritis

Area of Science:

• Rheumatology
• Vascular Biology
• Pathophysiology

Background:

• Angiogenesis is crucial in rheumatoid arthritis (RA) and osteoarthritis (OA) pathogenesis, promoting inflammation and pain.
• Mediators like vascular endothelial growth factor (VEGF) and hypoxia-inducible factors (HIFs) drive synovial angiogenesis.
• Current RA and OA treatments have limitations, including resistance, partial response, intolerance, and lack of disease-modifying effects.

Purpose of the Study:

• To review the literature on the therapeutic benefits of modulating angiogenic activity in experimental RA and OA.
• To identify new treatment targets by examining the role of angiogenesis in joint inflammation.

Main Methods:

• A narrative literature review of studies indexed in PubMed.
• Focus on evidence demonstrating the therapeutic potential of inhibiting angiogenesis in experimental models of RA and OA.

Main Results:

• Evidence suggests that modulating angiogenic activity holds therapeutic promise for RA and OA.
• Targeting angiogenesis could offer a novel approach to managing joint inflammation and disease progression.

Conclusions:

• Selective inhibition of synovial angiogenesis presents a promising therapeutic avenue for RA and OA.
• New treatments targeting angiogenesis may improve outcomes and prevent healthy tissue damage in patients with inflammatory joint diseases.